4 Month Progress (Min/Fin Oral, Micro-needling + Rosemary Oil every 4 days)
    Progress Pictures 2/6/2025

    From the encyclopedia
    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 1mg 1x daily 4 months
    πŸ’Š Minoxidil (oral) 2.5mg 2x daily 4 months
    πŸ’§ Micro-needling (topical) 1mm every 4 days 4 months
    πŸ’§ Rosemary Oil (topical) every 4 days 4 months
    the tone is πŸ˜€ positive with significant regrowth results.

    Other terms

    The user experienced significant hair regrowth over four months using oral finasteride, oral minoxidil, micro-needling, and rosemary oil. They reported no side effects and emphasized the importance of continuing the treatment to maintain results.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      Androgenetic Alopecia: Therapy Update

      research Androgenetic Alopecia: Therapy Update

      May 2023 in “Drugs”
      This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
      Androgenetic Alopecia: Update on Etiology, Pathophysiology, Diagnosis, and Treatment

      research Androgenetic Alopecia: update on Etiology, Pathophysiology, Diagnosis and Treatment

      March 2024 in “International journal of pharmaceutical sciences and drug research”
      In this review, the authors explored current and novel treatment options for androgenetic alopecia, noting both FDA-approved pharmacologic treatments like Minoxidil and Finasteride and various non-pharmacologic and surgical methods, including hair transplantation and scalp micro-pigmentation.
      A Canadian Consensus on Androgenetic Alopecia: Approach and Management

      research A Canadian Consensus on Androgenetic Alopecia: Approach and Management

      September 2025 in “Journal of Cutaneous Medicine and Surgery”
      This expert panel review developed consensus recommendations for managing androgenetic alopecia in Canadian adults, endorsing seven interventions like oral and topical medications and platelet-rich plasma.
      Advances in Hair Growth

      research Advances in hair growth

      1 citations , January 2022 in “Faculty reviews”
      This review discusses recent advances in understanding hair growth mechanisms and reviews current and emerging therapies, but it presents no new clinical results.